Surgery, radiation, and chemo are traditionally used to treat this common type with a high risk of recurrence. But have you heard of CDK4/6 inhibitors?
Learn about your treatment options for early stage II and III HR+/HER2- breast cancer.
It is important to have a say in your treatment for HR+/HER2- early breast cancer. Learn the best way to do that.
You’ll get a better understanding of treatment options when you know the things that guide your doctor’s recommendations. Learn about what they consider.
When you have early-stage breast cancer, you may feel your world is turned upside down. Learn how to get your emotions back on track.
Learn about what affects your breast cancer recurrence risk, how risk can change your treatment choices, and how to lower your odds of cancer returning.
Making sure a diverse set of people take part in clinical trials can mean they’re more effective for all patients. Learn how from the ASCO conference.
Breast cancer patient advocates were among those attending the American Society of Clinical Oncology Annual Meeting. Find out about their contributions.
New research suggests most young women can have kids after breast cancer treatment. Find out the details.